Dr Ian Waddell has more than 27 years of experience across all stages of drug discovery. His expertise spans cardiovascular and oncology disease areas, and his leadership in the field has been instrumental in advancing drug development programs.
Scientific Advisory
Director of Protein and Structural Sciences
Director of Medicinal Chemistry
Translational Biology Services Director
Chief Executive Officer
Chief Financial Officer
Head of US Sales
Chief Operating Officer
Biology Services Director
Drug Discovery Services Director
CMC Services Director
Director of Toxicology and Bioanalytical
Chemistry Services Director